In the Boardroom

Filter

Current filters:

None

Popular Filters

1 to 25 of 209 results

Takeda US president quits

21-11-2014

The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole,…

BoardroomManagementPharmaceuticalTakeda PharmaceuticalUSA

Ablynx appoints ex-GSK director Johan Heylen as chief commercial officer

Ablynx appoints ex-GSK director Johan Heylen as chief commercial officer

18-11-2014

Belgian drug developer Ablynx has announced the appointment of Johan Heylen as chief commercial officer.

AblynxBelgiumBoardroomJohan HeylenPharmaceuticalVrije Universiteit Brussel

Actavis appoints Maria Teresa Hilado as chief financial officer

Actavis appoints Maria Teresa Hilado as chief financial officer

12-11-2014

Ireland-headquartered generics major Actavis has appointed Maria Teresa (Tessa) Hilado as chief financial…

ActavisBoardroomCFOIrelandPharmaceutical

Reckitt Benckiser appoints Cary Claiborne as chief financial officer

Reckitt Benckiser appoints Cary Claiborne as chief financial officer

04-11-2014

Global specialty pharma company Reckitt Benckiser has appointed Cary Claiborne as chief financial officer.

BoardroomCary ClaiborneChief financial officerPharmaceuticalReckitt Benckiser

aTyr Pharma appoints Fred Ramsdell as vice president of immunology

aTyr Pharma appoints Fred Ramsdell as vice president of immunology

03-11-2014

Rare disease specialist aTyr Pharma has appointed Fred Ramsdell as vice president of immunology.

aTyrBoardroomNovo NordiskPharmaceuticalUSA

Synthetic Genomics appoints Oliver Fetzer as chief executive

Synthetic Genomics appoints Oliver Fetzer as chief executive

29-10-2014

Synthetic biology company Synthetic Genomics has appointed Oliver Fetzer as the company’s new chief…

BiotechnologyBoardroomSGISynthetic GenomicsUSA

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

23-10-2014

Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed…

BelgiumBiotechnologyBoardroomCardio3 BioSciencesCardio3 BioSciences

aTyr Pharma appoints John McKew as vice president of research

aTyr Pharma appoints John McKew as vice president of research

22-10-2014

US rare disease company aTyr Pharma has named John McKew as vice president of research.

aTyrBiotechnologyBoardroomNational Institutes of HealthUSA

Karus appoints Simon Roitt and Peter Finan

Karus appoints Simon Roitt and Peter Finan

21-10-2014

UK-based inflammatory disease and cancer specialist Karus Therapeutics has appointed Simon Roitt as head…

BoardroomKarusKarus TherapeuticsNovartisUK

AnaptysBio appoints Marco Londei as chief development officer

AnaptysBio appoints Marco Londei as chief development officer

20-10-2014

Therapeutic antibody specialist AnaptysBio has appointed Marco Londei as chief development officer, leading…

AnaptysBioBoardroomBristol-Myers SquibbMarco LondeiUSA

Grünenthal Group appoints Sascha Becker as group chief financial officer

Grünenthal Group appoints Sascha Becker as group chief financial officer

20-10-2014

German pharma company Grünenthal Group has appointed Sascha Becker as group chief financial officer,…

BoardroomGermanyGrunenthalMerck SeronoPharmaceutical

Shire interim chief financial officer James Bowling to step down after Q1 2015

Shire interim chief financial officer James Bowling to step down after Q1 2015

20-10-2014

James Bowling, interim chief financial officer of Ireland-headquartered drugmaker Shire, has stepped…

BoardroomJames BowlingPharmaceuticalShireUK

Bruno Lucidi appointed permanent CEO of Karolinska Development

Bruno Lucidi appointed permanent CEO of Karolinska Development

15-10-2014

Swedish drug developer Karolinska Development has named Bruno Lucidi as permanent chief executive.

BoardroomKarolinska DevelopmentManagementPharmaceuticalSweden

Increase in women appointed to life science boards, but their talent needs to be better managed

Increase in women appointed to life science boards, but their talent needs to be better managed

14-10-2014

Although life science company boards are recruiting more women, a lack of managing their talent during…

BoardroomBusinessCorporate governanceManagementPharmaceutical

Bengt Julander appointed chairman of the board at Pharmalink

Bengt Julander appointed chairman of the board at Pharmalink

14-10-2014

Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the…

BoardroomPharmaceuticalPharmaLinkPharmaLinkSweden

Three members of Novartis’ executive committee will leave company in 2015

Three members of Novartis’ executive committee will leave company in 2015

09-10-2014

Swiss drug major Novartis has announced that three members of its executive committee will leave the…

BoardroomEli LillyGlaxoSmithKlineNovartisPharmaceuticalSwitzerland

Norgine appoints Christopher Bath as vice president of global finance

Norgine appoints Christopher Bath as vice president of global finance

08-10-2014

European specialty pharmaceutical company Norgine has appointed Christopher Bath as vice president of…

BoardroomBusiness FinanceChristopher BathNorginePharmaceutical

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

08-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president…

Anti-viralsBoardroomJapanPharmaceuticalTakeda Pharmaceutical

Aeterna Zentaris names Philip Theodore as SVP

Aeterna Zentaris names Philip Theodore as SVP

07-10-2014

Canadian biopharmaceutical company Aeterna Zentaris has named Philip Theodore as senior vice president,…

Aeterna ZentarisBoardroomCanadaPharmaceuticalPhilip Theodore

PDL BioPharma appoints Danny Hart as vice president of business development

PDL BioPharma appoints Danny Hart as vice president of business development

06-10-2014

PDL BioPharma has appointed Danny Hart as vice president of business development.

BiotechnologyBoardroomDanny HartPDL BioPharmaUSA

Satish Jindal appointed to lead drug discovery at Allied-Bristol Life Sciences

Satish Jindal appointed to lead drug discovery at Allied-Bristol Life Sciences

06-10-2014

Satish Jindal has been appointed to lead the discovery of drug candidates from leading academic institutions…

Allied MindsBoardroomBristol-Myers SquibbPharmaceuticalUSA

Mast Therapeutics names Edwin Parsley as CMO

Mast Therapeutics names Edwin Parsley as CMO

02-10-2014

US-based clinical biopharmaceutical company Mast Therapeutics has named Edwin Parsley, has joined the…

BoardroomMast TherapeuticsPharmaceuticalUSA

1 to 25 of 209 results

Parexel

Parexel

Back to top